Cronos Group Stock Price, News & Analysis

Cronos (NASDAQ: CRON) is reintroducing its limited-edition SOURZ by Spinach Caramel Green Apple flavor for the Fall and Halloween 2025 season. The rollout returns the original Caramel Green Apple 5-pack gummies and adds two new fall exclusives: a Fully Blasted Caramel Green Apple 10mg THC gummy and a Spinach Sweet Green Apple 1g Sativa vape infused with liquid diamonds.

The flavor first launched in Fall 2024; the seasonal products are available now across Canada. For product details and store availability, the company directs consumers to the Spinach website.

Cronos Group (NASDAQ: CRON) will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET. Senior management will discuss the company’s financial results and take questions after prepared remarks.

Participants must register to attend the call or webcast at https://ir.thecronosgroup.com/events-presentations. The company recommends dialing in 15 minutes early to avoid delays. A webcast replay will be archived on the company website.

Cronos (NASDAQ: CRON) announced on October 9, 2025 that its SOURZ by Spinach Fully Blasted gummies will be sold in new multipack formats featuring liquid diamond‑infused gummies.

Products will launch in 5‑pack (5 x 10mg THC) and 10‑pack (10 x 10mg THC; one 10mg THC|10mg CBD SKU) configurations across five core flavors and will be available now in Alberta, British Columbia, Manitoba, Newfoundland, Nova Scotia, Ontario, Prince Edward Island, and Saskatchewan.

Management highlighted that SOURZ by Spinach holds just over 20% market share and has ranked as the #1 edible in Canada since September 2024, positioning the multipacks as a convenience and value play for existing customers.

Cronos Group (NASDAQ: CRON) reported strong Q2 2025 results with net revenue increasing 21% year-over-year to $33.5 million. The company achieved its highest-ever international and Israel revenue, with PEACE NATURALS® maintaining its position as the top cannabis brand in Israel.

Key financial metrics include gross profit of $14.5 million (up 130% YoY), improved gross margin to 43%, and Adjusted EBITDA of $1.7 million. The company maintains a strong balance sheet with $834 million in cash and short-term investments.

Notable developments include Spinach® ranking as Canada's second most popular cannabis brand with 4.7% market share, completion of the Cronos GrowCo expansion, and a strategic C$25.2 million investment in High Tide Inc. The company also successfully resolved the Israeli anti-dumping duty issue and expanded PEACE NATURALS® into new international markets.

Cronos Group (NASDAQ: CRON) has scheduled its 2025 second quarter earnings conference call for Thursday, August 7, 2025 at 8:30 a.m. ET. The company's senior management will present financial results and conduct a Q&A session with the investment community.

Participants can register for the call and webcast through the company's investor relations website. To ensure timely participation, attendees are encouraged to dial in fifteen minutes before the scheduled start time. A replay of the webcast will be available on Cronos Group's website after the event.

High Tide Inc. (NASDAQ: HITI) has secured a $30 million convertible debt through a loan agreement with Cronos Group Inc. The junior secured loan bears a 4% annual interest rate and has a 5-year term. The debt is convertible into High Tide common shares at $4.20 per share.

As part of the deal, Cronos received a warrant exercisable into 3,836,317 common shares at $3.91 per share, representing a 25% premium to the 30-day VWAP. High Tide plans to use the capital for future acquisitions and organic growth, aiming to expand its Canadian store network beyond 300 locations. The company currently operates 202 Canna Cabana locations across Canada, making it the second-largest cannabis retailer globally by store count.

Cronos Group (NASDAQ: CRON) has announced its expansion into the Swiss medical cannabis market through a partnership with Dascoli Pharma AG. Under the agreement, Cronos will supply its PEACE NATURALS® branded cannabis flower products through Dascoli's established medical network in Switzerland.

The expansion includes five cannabis flower varieties: GMO Cookies, Space Cake, Atomic Sour Grapefruit, Sonic Lemon Fuel, and Wedding Cake. The PEACE NATURALS® brand is now available in seven international markets, including Australia, Canada, Germany, Israel, Malta, Switzerland, and the UK.

Cronos Group (NASDAQ: CRON) announced the results of its 2025 Annual Meeting of Shareholders, with a 71.87% shareholder participation representing 276,989,452 common shares. All nominated directors were successfully elected with over 92.3% approval rates. Notably, shareholders approved the executive compensation advisory resolution with 94.13% support and confirmed Davidson & Company LLP as the independent auditor for fiscal year 2025.

The board election saw strong support for all directors, with Dominik Meier receiving the highest approval at 96.94%, followed by Kamran Khan at 96.92%. Michael Gorenstein received 92.38% of votes in favor, representing the lowest but still overwhelmingly positive support among the directors.

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), a global cannabinoid company, announced that its Chairman, President and CEO Mike Gorenstein will participate in the TD Cowen 9th Annual Future of the Consumer Conference. The presentation is scheduled for Wednesday, June 4, 2025, at 3:30 p.m. EST. Investors and interested parties can access the live webcast through the Investors section of Cronos Group's website at ir.thecronosgroup.com/events-presentations.